Diagnosing ‘Migraine’: A Default Button?

The ‘default button’ concept in diagnosis is analogous to the Pavlovian response, a learned, automatic reaction that occurs involuntarily when a previously neutral stimulus becomes conditioned to trigger it.

One significant conceptual barrier in clinical practice is recognising that a diagnosis doesn’t always benefit the patient. From my clinical experience, labelling a patient with a ‘migraine’ diagnosis does not necessarily lead to improved treatment outcomes.

In medical classification, taxonomists distinguish between clinical-symptomatic and etiologic approaches. Clinical-symptomatic classifications group diseases based on clusters of symptoms and outward features, while etiologic classifications delve into the underlying mechanisms and biological causes. For example, the clinical-symptomatic classification of pneumonia might include symptoms like a productive cough, fever, chills, and diminished breath sounds. On the other hand, an etiologic classification would differentiate between pneumococcal, chlamydial, and viral pneumonias. While etiologic systems require more detailed knowledge, they are better suited to predict the clinical course, prognosis, and response to treatment.

The International Classification of Headache Disorders-3 (ICHD-3) currently offers an etiologic classification for secondary headaches but relies on a clinical-symptomatic approach for primary headaches. This raises the question: What tangible benefit does a ‘migraine’ diagnosis provide patients?

Overcoming cognitive biases can aid in achieving an accurate diagnosis, but accuracy alone is not enough to ensure that the diagnosis is valuable or beneficial to the patient. Similarly, while current clinical decision-making models emphasise treatment choices, they often place medical diagnoses outside this framework, leaving no room for choice in diagnosis.

Teaching evidence-based medicine is essential, but it is equally important to incorporate evidence-informed practice that can be applied directly to clinical diagnosis and management. Medical and manual therapy students should be encouraged to engage with evidence critically rather than defaulting to guidelines.

Another conceptual barrier in migraine management is recognising that diagnosis is not a separate activity but an integral part of clinical management. Like all aspects of clinical management, diagnosis involves making choices. Some argue that clinical decision-making differs fundamentally between diagnosis and treatment. However, suppose we view clinical decision-making as a continuum from initial presentation to the completion of care. In that case, the same questions applicable to treatment decisions also apply to diagnostics: Will this benefit my patient? What is the best choice for this situation?

In the context of migraine management, an accurate diagnosis requires identifying the type of headache and understanding the underlying mechanisms, such as the role of cervical afferents and central sensitisation. It is crucial to remember that the ICHD-3 is designed to diagnose the headache, not the underlying condition. Furthermore, the Cervicogenic Headache criteria, do not specify the particulars or the skills necessary for making a causative diagnosis.

By integrating diagnosis into the continuum of care, clinicians can make more informed decisions that directly benefit their patients. This approach ensures that management strategies are tailored to the specific needs of each individual with migraine, ultimately improving outcomes.